BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28942393)

  • 1. Prognostic value of galectin-3 in adults with congenital heart disease.
    Baggen VJM; van den Bosch AE; Eindhoven JA; Menting ME; Witsenburg M; Cuypers JAAE; Boersma E; Roos-Hesselink JW
    Heart; 2018 Mar; 104(5):394-400. PubMed ID: 28942393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of soluble ST2 in adults with congenital heart disease.
    Geenen LW; Baggen VJM; van den Bosch AE; Eindhoven JA; Cuypers JAAE; Witsenburg M; Boersma E; Roos-Hesselink JW
    Heart; 2019 Jul; 105(13):999-1006. PubMed ID: 30700520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Value of Serial N-Terminal Pro-B-Type Natriuretic Peptide Measurements in Adults With Congenital Heart Disease.
    Baggen VJM; Baart SJ; van den Bosch AE; Eindhoven JA; Witsenburg M; Cuypers JAAE; Roos-Hesselink JW; Boersma E
    J Am Heart Assoc; 2018 Mar; 7(7):. PubMed ID: 29581225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide, Troponin-T, and Growth-Differentiation Factor 15 in Adult Congenital Heart Disease.
    Baggen VJ; van den Bosch AE; Eindhoven JA; Schut AW; Cuypers JA; Witsenburg M; de Waart M; van Schaik RH; Zijlstra F; Boersma E; Roos-Hesselink JW
    Circulation; 2017 Jan; 135(3):264-279. PubMed ID: 27832613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Red cell distribution width in adults with congenital heart disease: A worldwide available and low-cost predictor of cardiovascular events.
    Baggen VJM; van den Bosch AE; van Kimmenade RR; Eindhoven JA; Witsenburg M; Cuypers JAAE; Leebeek FWG; Boersma E; Roos-Hesselink JW
    Int J Cardiol; 2018 Jun; 260():60-65. PubMed ID: 29525069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galectin-3 Is Elevated and Associated With Adverse Outcomes in Patients With Single-Ventricle Fontan Circulation.
    Opotowsky AR; Baraona F; Owumi J; Loukas B; Singh MN; Valente AM; Wu F; Cheng S; Veldtman G; Rimm EB; Landzberg MJ
    J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26755550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Value of Serial High-Sensitivity Troponin T Measurements in Adults With Congenital Heart Disease.
    Geenen LW; Baggen VJM; van den Bosch AE; Eindhoven JA; Kauling RM; Cuypers JAAE; Roos-Hesselink JW; Boersma E
    Can J Cardiol; 2020 Sep; 36(9):1516-1524. PubMed ID: 32297863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective Validation of a Screening Biomarker Approach Combining Amino-Terminal Pro-Brain Natriuretic Peptide With Galectin-3 Predicts Death and Cardiovascular Events in Asymptomatic Hemodialysis Patients.
    Voroneanu L; Siriopol D; Apetrii M; Hogas S; Onofriescu M; Nistor I; Kanbay M; Dumea R; Cusai S; Cianga P; Constantinescu D; Covic A
    Angiology; 2018 May; 69(5):449-455. PubMed ID: 28974104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and prognostic implications of plasma NGAL and NT-proBNP in adult patients with congenital heart disease.
    Frogoudaki A; Andreou C; Parissis J; Maniotis C; Nikolaou M; Rizos I; Filippatos G; Lekakis J
    Int J Cardiol; 2014 Dec; 177(3):1026-30. PubMed ID: 25449518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-terminal pro-B-type natriuretic peptide and its relationship with cardiac function in adults with congenital heart disease.
    Eindhoven JA; van den Bosch AE; Ruys TP; Opić P; Cuypers JA; McGhie JS; Witsenburg M; Boersma E; Roos-Hesselink JW
    J Am Coll Cardiol; 2013 Sep; 62(13):1203-12. PubMed ID: 23916937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galectin-3: a new biomarker for the diagnosis, analysis and prognosis of acute and chronic heart failure.
    Hrynchyshyn N; Jourdain P; Desnos M; Diebold B; Funck F
    Arch Cardiovasc Dis; 2013 Oct; 106(10):541-6. PubMed ID: 24090952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B-type natriuretic peptide levels predict long-term mortality in a large cohort of adults with congenital heart disease.
    Yumita Y; Xu Z; Diller GP; Kempny A; Rafiq I; Montanaro C; Li W; Gu H; Dimopoulos K; Niwa K; Gatzoulis MA; Brida M
    Eur Heart J; 2024 Jun; 45(23):2066-2075. PubMed ID: 38743452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of galectin-3 on admission in Chinese patients with heart failure: a prospective observational study.
    Wang H; Chen Q; Li Y; Jing X; Liang T; Yang J
    Acta Cardiol; 2017 Apr; 72(2):188-195. PubMed ID: 28597803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the Prognostic Value of Novel Markers in Adults With a Systemic Right Ventricle.
    Geenen LW; van Grootel RWJ; Akman K; Baggen VJM; Menting ME; Eindhoven JA; Cuypers JAAE; Boersma E; van den Bosch AE; Roos-Hesselink JW
    J Am Heart Assoc; 2019 Sep; 8(17):e013745. PubMed ID: 31431113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-sensitive troponin-T in adult congenital heart disease.
    Eindhoven JA; Roos-Hesselink JW; van den Bosch AE; Kardys I; Cheng JM; Veenis JF; Cuypers JAAE; Witsenburg M; van Schaik RHN; Boersma E
    Int J Cardiol; 2015 Apr; 184():405-411. PubMed ID: 25746495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute cardiac dyspnea in the emergency department: diagnostic value of N-terminal prohormone of brain natriuretic peptide and galectin-3.
    Stoica A; Şorodoc V; Lionte C; Jaba IM; Costache I; Anisie E; Tuchiluș C; Rusalim Petriș O; Sîrbu O; Jaba E; Ceasovschih A; Vâţă L; Şorodoc L
    J Int Med Res; 2019 Jan; 47(1):159-172. PubMed ID: 30222016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of N-Terminal Pro-Brain Natriuretic Peptide to Predict Mortality in Adults With Congenital Heart Disease.
    Popelová JR; Kotaška K; Tomková M; Tomek J
    Am J Cardiol; 2015 Nov; 116(9):1425-30. PubMed ID: 26404943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Red blood cell distribution width in addition to N-terminal prohormone of B-type natriuretic peptide concentration improves assessment of risk of cardiovascular events in adult patients with congenital heart disease.
    Martínez-Quintana E; Estupiñán-León H; Riaño-Ruiz M; Rodríguez-González F; Tugores A
    Arch Cardiovasc Dis; 2020 Oct; 113(10):607-616. PubMed ID: 33039325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Utility of Galectin-3 for Recurrent Cardiovascular Events During Long-term Follow-up in Patients with Stable Coronary Heart Disease: Results of the KAROLA Study.
    Jansen H; Koenig W; Jaensch A; Mons U; Breitling LP; Scharnagl H; Stojakovic T; Schunkert H; Brenner H; Rothenbacher D
    Clin Chem; 2016 Oct; 62(10):1372-9. PubMed ID: 27540030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Research on clinical value of galectin-3 in evaluating the prognosis of acute heart failure.
    Zhang T; Shao B; Liu GA
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(19):4406-4410. PubMed ID: 29077153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.